-
Subject Areas on Research
-
A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.
-
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.
-
A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer.
-
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.
-
Aqueous shunt devices compared with trabeculectomy with Mitomycin-C for children in the first two years of life.
-
Aqueous shunt devices compared with trabeculectomy with mitomycin-C for children in the first two years of life.
-
Arabidopsis BRCA2 and RAD51 proteins are specifically involved in defense gene transcription during plant immune responses.
-
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
-
Atypical Fibroxanthoma of the Bulbar Conjunctiva.
-
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
-
Can topical mitomycin prevent laryngotracheal stenosis?
-
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
-
Characterization of Acyl Carrier Protein-Dependent Glycosyltransferase in Mitomycin C Biosynthesis.
-
Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
-
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice.
-
Clinical trial of high dose hyperthermic intravesical mitomycin C for intermediate and high-risk non-muscle invasive bladder cancer during BCG shortage.
-
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
-
Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
-
Current management of anal canal cancer.
-
DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.
-
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
-
Echographic diagnosis of scleral fold in hypotony.
-
Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
-
Efficacy of epidural blood patching or surgery in spontaneous intracranial hypotension: an evidence map protocol.
-
Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.
-
Evolution and Management of Treatment-Related Toxicity in Anal Cancer.
-
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
-
Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy.
-
Genetic composition of the Bacillus subtilis SOS system.
-
Heated Intravesical Chemotherapy: Biology and Clinical Utility.
-
Histology of conjunctival vascular endothelium after filtering surgery with mitomycin C in rabbits.
-
Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
-
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
-
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.
-
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
-
Increasing dwell time of mitomycin C in the upper tract with a reverse thermosensitive polymer.
-
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
-
Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
-
Intensity-modulated radiation therapy for anal cancer.
-
Interaction of FANCD2 and NBS1 in the DNA damage response.
-
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.
-
Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors.
-
Laser suture lysis after mitomycin C trabeculectomy.
-
Lisch nodules after trabeculectomy.
-
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
-
Management of Lung Transplant Bronchial Stenosis With Mitomycin C.
-
Management of suprachoroidal hemorrhage.
-
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
-
Migrating keratinocytes express urokinase-type plasminogen activator.
-
Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial.
-
Mitomycin C and menadione for the treatment of lung cancer: a phase II trial.
-
Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma.
-
Mitomycin-C concentration in human aqueous humour following trabeculectomy.
-
Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
-
NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.
-
Phase I study of mitomycin C and menadione in advanced solid tumors.
-
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor.
-
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
-
Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of Mitomycin C Prodrug, in Chemoradiotherapy.
-
Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
-
Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells.
-
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC.
-
RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.
-
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
-
Repair of mitomycin C cross-linked DNA in mammalian cells measured by a host cell reactivation assay.
-
Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.
-
Retinal vein occlusion after trabeculectomy with mitomycin C.
-
Review of results from the Tube Versus Trabeculectomy Study.
-
Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.
-
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.
-
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
-
Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer.
-
Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
-
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
-
The Short-term Effect of Subtenon Sponge Application Versus Subtenon Irrigation of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device: A Randomized Trial.
-
The Tube Versus Trabeculectomy Study: interpretation of results and application to clinical practice.
-
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
-
The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
-
The tube versus trabeculectomy study: design and baseline characteristics of study patients.
-
Three-dimensional high-speed optical coherence tomography for diagnosis of hypotony maculopathy after glaucoma filtration surgery.
-
Three-year follow-up of the tube versus trabeculectomy study.
-
Time-dose considerations in the treatment of anal cancer.
-
Trabeculectomy in pseudophakic patients: postoperative 5-fluorouracil versus intraoperative mitomycin C antiproliferative therapy.
-
Trabeculectomy with mitomycin-C in pediatric glaucomas.
-
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
-
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
-
Treatment of superficial carcinoma of the bladder.
-
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
-
Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
-
Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up.
-
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
-
Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
-
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
-
Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.
-
Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat.
-
Keywords of People